Trade Surface Oncology - SURF CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.05 |
| Open | 1.02 |
| 1-Year Change | -21.54% |
| Day's Range | 0.99 - 1.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 7, 2023 | 1.05 | 0.03 | 2.94% | 1.02 | 1.05 | 0.99 |
| Sep 6, 2023 | 1.05 | 0.07 | 7.14% | 0.98 | 1.08 | 0.98 |
| Sep 5, 2023 | 0.99 | -0.06 | -5.71% | 1.05 | 1.05 | 0.98 |
| Sep 1, 2023 | 1.06 | 0.02 | 1.92% | 1.04 | 1.08 | 1.02 |
| Aug 31, 2023 | 1.05 | 0.03 | 2.94% | 1.02 | 1.06 | 1.01 |
| Aug 30, 2023 | 1.04 | 0.02 | 1.96% | 1.02 | 1.06 | 1.02 |
| Aug 29, 2023 | 1.03 | 0.07 | 7.29% | 0.96 | 1.04 | 0.96 |
| Aug 28, 2023 | 0.98 | 0.03 | 3.16% | 0.95 | 0.98 | 0.92 |
| Aug 25, 2023 | 0.93 | 0.02 | 2.20% | 0.91 | 0.93 | 0.91 |
| Aug 24, 2023 | 0.93 | 0.02 | 2.20% | 0.91 | 0.93 | 0.89 |
| Aug 23, 2023 | 0.92 | 0.00 | 0.00% | 0.92 | 0.96 | 0.92 |
| Aug 22, 2023 | 0.89 | -0.01 | -1.11% | 0.90 | 0.92 | 0.87 |
| Aug 21, 2023 | 0.90 | 0.02 | 2.27% | 0.88 | 0.92 | 0.87 |
| Aug 18, 2023 | 0.88 | 0.05 | 6.02% | 0.83 | 0.89 | 0.83 |
| Aug 17, 2023 | 0.86 | -0.02 | -2.27% | 0.88 | 0.89 | 0.85 |
| Aug 16, 2023 | 0.88 | -0.01 | -1.12% | 0.89 | 0.90 | 0.88 |
| Aug 15, 2023 | 0.89 | 0.01 | 1.14% | 0.88 | 0.89 | 0.86 |
| Aug 14, 2023 | 0.88 | -0.02 | -2.22% | 0.90 | 0.91 | 0.87 |
| Aug 11, 2023 | 0.91 | -0.01 | -1.09% | 0.92 | 0.92 | 0.90 |
| Aug 10, 2023 | 0.92 | 0.02 | 2.22% | 0.90 | 0.94 | 0.90 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Surface Oncology Company profile
About Surface Oncology Inc
Surface Oncology, Inc. is a clinical-stage, immuno-oncology company focused on developing antibody therapies focused on the tumor microenvironment. The Company is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable an immunologic response and enhance outcomes for patients with cancer. Its pipeline includes two wholly owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a pre-clinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). In addition, Surface has two partnerships with pharmaceutical companies, including a collaboration with Novartis targeting CD73 (NZV930; Phase I) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813; preclinical).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Surface Oncology Inc revenues decreased 98% to $2.7M. Net loss totaled $78.5M vs. income of $59.3M. Revenues reflect License-related revenue decrease of 97% to $2.7M, Collaboration revenue - related party decrease from $38.6M to $0K. Net loss reflects Research and development - Balancing increase of 34% to $48.5M (expense), Stock-based Compensation in SGA increase of 24% to $6.1M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
50 Hampshire Street, 8Th Floor
CAMBRIDGE
MASSACHUSETTS 02139
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com